ANTON PORSTEINSSON: Open Payments
NPI 1740225028 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$42,945 in 16 payments from 5 companies in 2025. Trend: 2023 $25,606 · 2024 $50,265 · 2025 $42,945
Consulting: $42,865Food & beverage: $80
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $16,830 |
| Eli Lilly and Company | 2 | $16,675 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $8,640 |
| Biogen, Inc. | 1 | $720 |
| F. Hoffmann-La Roche AG | 1 | $80 |
Products named: REXULTI.
Industry payments across NY — which companies pay providers there.
